Correlation between chronic rhinosinusitis and laryngopharyngeal reflux
Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 4
Abstract
Background: Chronic rhinosinusitis (CRS) is a major Ear, Nose and Throat disease and there are higher numbers of refractory cases poorly responding to medical and surgical treatment. Laryngopharyngeal reflux (LPR) is said to be the important cause for same. Aims and Objectives: This study aims to study the incidence of LPR in patients of refractory CRS. This study also aims to study the impact of proton pump inhibitors (PPI) (effective treatment of LPR) given as adjuvant therapy along with functional endoscopic sinus surgery (FESS) in patients with refractory CRS. Materials and Methods: A total of 40 patients of refractory CRS taken up for the study were evaluated for signs and symptoms of LPR. They were then divided into two groups of 20 each - study group and control group. All the patients in both groups were evaluated for signs and symptoms of CRS. All these patients underwent FESS. Post-surgery patients in the study group were given intranasal steroids (INS) along with PPI (tablet pantoprazole) whereas in control group were put on INS without PPI. The patients were followed monthly for 3 months for improvement in signs and symptoms of CRS and patient’s relief and comfortability levels. Results: 45% of patients of refractory CRS had LPR with the posterior larynx being mainly involved. The major signs and symptoms of CRS were nasal obstruction, nasal discharge, and nasal polyps. There was more improvement in nasal obstruction, nasal discharge, and post-nasal discharge in patients of study group with PPI as compared to control group without PPI. There was better relief of symptoms in patients given PPI as compared to control group and this improvement was more marked at 3rd post-operative visit after 3 months. Conclusion: There is a strong association between refractory CRS and LPR. PPI are an effective drug for refractory CRS when given as adjuvant therapy along with FESS.
Authors and Affiliations
Manpreet Singh Nanda, Mandeep Kaur, Vipan Gupta
Keywords
Related Articles
- EP ID EP487788
- DOI 10.5455/njppp.2018.8.1145801122017
- Views 73
- Downloads 0
Effect of non-absorbable antibiotic, rifaximin in patients with irritable bowel syndrome: A single-center randomized controlled study
Background: Irritable bowel syndrome (IBS), most common functional bowel disease, does not have a definite treatment. Studies revealed the involvement of bacterial overgrowth for its pathology. The aim of this study is t...
Investigation the barriers and factors influencing the scientific productions of graduate students in Hamadan University of Medical Sciences
Background: The current study was conducted to investigate the research barriers and challenges faced by graduate students in Hamadan University of Medical Sciences. Aims and Objectives: This study is among the applied s...
Evaluating the clinical applications of visual evoked potentials in patients presenting with visual dysfunctions - A retrospective study
Background: The clinical applicability of visual evoked potential (VEP) tests has been progressively extending in neuro-ophthalmological workups. The role in monitoring and follow-ups are emerging as even more useful app...
Use of scenarios to increase the effectiveness of lecture-based sessions in pharmacology
Background: The current system of pharmacology teaching in India is mostly through lectures, which is a teacher oriented, monotonous and passive way of learning and does not encourage higher order thinking or ability to...
Lithium ascorbate as a protector of human blood biomolecules under ethanol impact
Background: Alcoholism is an acute social problem worldwide for negative impact on health. This problem is closely associated with social stress and drinking traditions. Previously, it was established exhaustion of blood...